2020
DOI: 10.7759/cureus.10025
|View full text |Cite
|
Sign up to set email alerts
|

A Case of COVID-19 With Memory Impairment and Delayed Presentation as Stroke

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory pathogen with remarkable properties of multisystem involvement and numerous complications. The coronavirus disease of 2019 (COVID-19) presenting as stroke is becoming more common. Herein, we describe an unusual case of COVID-19 in a patient who initially presented with myalgia, fatigue, loss of taste and smell, and non-specific memory impairment. Two months after infection with SARS-CoV-2, the patient presented with acute onset o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…Considering the aforementioned multifaceted features of ACE2 activity in the brain, one may assume that its downregulation may result in various deleterious consequences, such as deterioration of cognition ( Wang et al, 2016 ). Several reports suggest that COVID-19 can present with neurological deficits, including memory impairment ( Garg et al, 2020 ; Lu et al, 2020 ), which is also supported by a COVID-19 clinical update showing that individuals who recovered from COVID-19 perform worse on cognitive tests in multiple domains ( Hampshire et al, 2020 ; a preprint). Nevertheless, further studies are required to assess the involvement of altered ACE2 activity in COVID-19 neurological manifestations.…”
Section: Coronaviruses (Family Coronaviridae )mentioning
confidence: 83%
“…Considering the aforementioned multifaceted features of ACE2 activity in the brain, one may assume that its downregulation may result in various deleterious consequences, such as deterioration of cognition ( Wang et al, 2016 ). Several reports suggest that COVID-19 can present with neurological deficits, including memory impairment ( Garg et al, 2020 ; Lu et al, 2020 ), which is also supported by a COVID-19 clinical update showing that individuals who recovered from COVID-19 perform worse on cognitive tests in multiple domains ( Hampshire et al, 2020 ; a preprint). Nevertheless, further studies are required to assess the involvement of altered ACE2 activity in COVID-19 neurological manifestations.…”
Section: Coronaviruses (Family Coronaviridae )mentioning
confidence: 83%
“…These results were consistent with previous international findings. 40 COVID-19-affected patients have been related to a higher risk of cognitive impairment after resolving the primary infection, according to previous studies. 41 The cognitive impairment reported in the earlier studies suggests the need for long-term follow up of the COVID-affected subjects.…”
Section: Discussionmentioning
confidence: 78%
“…The remaining 71 articles (127 patients) that satisfied the criteria mentioned above were included in this review. In this review, 80 cases of patients developed IS during COVID-19 infection (Aasfara et al 2021 ; Abdulkadir et al 2020 ; Agarwal et al 2020 ; Al-Mufti et al 2021 ; Al Saiegh et al 2020 ; Appavu et al 2021 ; Ashraf and Sajed 2020 ; Avula et al 2020 ; Bessa et al 2020 ; Bigliardi et al 2020 ; Burkert and Patil 2020 ; Co et al 2020 ; Dakay et al 2020a , b ; de Almeida Lima et al 2020 ; de Lorenzo Alvarez et al 2021 ; Deliwala et al 2020 ; Dumitrascu et al 2020 ; Efendizade et al 2020 ; El Nahas et al 2020 ; Elshereye and Erdinc 2020 ; Eskandarani et al 2021 ; Fu et al 2021 ; Garg et al, 2020 ; Gemcioglu et al 2020 ; Goette et al 2020 ; Goldberg et al 2020 ; Guillan et al 2020 ; Iqbal et al 2021 ; Kwon et al 2020 ; Mahboob et al 2020 ; Mansour et al 2020 ; Mirzaee et al 2020 ; Morassi et al 2020 ; Mowla et al 2020 ; Patel et al 2020a , b ; Patel et al 2020a , b ; Prasad et al 2021 ; Priftis et al 2020 ; Rajdev et al 2020 ; Rascón-Ramírez et al 2020 ; Roy et al 2021 ; Valderrama et al 2020 ; Viguier et al 2020 ; Zhai et al 2020 ), 32 cases developed intracranial hemorrhage (Ahmad et al 2021 ; Al-Mufti et al 2021 ; Al Saiegh et al 2020 ; Carroll and Lewis 2021 ; Cezar-Junior et al 2020 ; Dakay et al 2020a , b ; Dakay et al 2020a , ...…”
Section: Resultsmentioning
confidence: 99%